Photo from academic.microsoft.com
As more biosimilars become available in the United States, postapproval noninterventional studies describing biosimilar switching and comparing effectiveness and/or safety between switchers and nonswitchers will play a key role in… Click to show full abstract
As more biosimilars become available in the United States, postapproval noninterventional studies describing biosimilar switching and comparing effectiveness and/or safety between switchers and nonswitchers will play a key role in generating real‐world evidence to inform clinical practices and policy decisions. Ensuring sound methodology is critical for making valid inferences from these studies.
Keywords:
studies switching;
reference biologic;
noninterventional studies;
switching reference;
methodologic considerations;
considerations noninterventional
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!